Riskpilot← Back to searchSign inGet full accessCareDx AB
ABActiveOrg 5565507257Franzéngatan 5Manufacture of other chemical products n.e.c. · NACE 2059Est. 199754 employees
Revenue 2024
SEK 208,8M
+27% vs 2023
EBITDA margin
-2.1%
+43% vs 2023
Equity ratio
63.1%
Financial strength
Net profit 2024
SEK -27,3M
+7% vs 2023
| Revenue | SEK 208,8M | +27% |
| EBITDA | SEK -4,4M | +43% |
| Net profit | SEK -27,3M | +7% |
| Total assets | SEK 263,7M | +19% |
| Equity | SEK 166,4M | -14% |
| Employees | 54 | — |
Legal name
CareDx AB
Org number
5565507257
Legal form
Aktiebolag
NACE code
2059 · Manufacture of other chemical products n.e.c.
Founded
18 december 1997
Share capital
SEK 150 000
Employees
54 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Hedlund, Anna Märtha Meng, Jessica
Company purpose
Föremålet för bolaget verksamhet är att bolaget ska tillverka reagenser för molekylärbiologisk medicinsk verksamhet, företrädesvis inom tranplantaionsområdet ävensom idka därmed förenlig verksamhet. Bolaget ska jämväl bedriva handel med värdepapper.
Address
Franzéngatan 5
Email
finance-se@caredx.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 66 545 | 66 177 | 58 775 | 117 325 | 137 794 | 164 289 | 208 829 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 21 477 | 7 829 | −11 493 | −30 545 | −15 201 | −38 573 | −2 256 | 6 238 | −7 624 | −4 374 |
| Depreciation & amort. | −697 | −1 414 | −1 528 | −1 722 | −1 700 | −1 883 | −641 | −21 348 | −21 664 | −22 019 |
| EBIT | 20 780 | 6 415 | −13 021 | −32 267 | −16 901 | −40 456 | −2 897 | −15 110 | −29 288 | −26 393 |
| Net financials | −180 | −3 833 | −3 209 | 7 788 | −10 539 | 6 093 | 1 090 | 1 340 | −1 360 | −1 333 |
| Profit before tax | −4 049 | −2 772 | −26 230 | −22 751 | −19 898 | −32 926 | −1 807 | −13 770 | −29 251 | −27 299 |
| Tax | −0 | −0 | −1 008 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −4 049 | −2 772 | −27 238 | −22 751 | −19 898 | −32 926 | −1 807 | −13 770 | −29 251 | −27 299 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 46 477 | 122 699 | 130 655 | 114 853 | 107 247 | 129 225 | 129 229 | 206 504 | 221 108 | 263 650 |
| Equity | 22 253 | 19 481 | 44 250 | 56 843 | 36 943 | 81 387 | 75 604 | 149 098 | 193 887 | 166 356 |
| Long-term debt | 0 | 83 660 | 5 304 | 550 | 49 247 | 0 | 14 390 | 17 594 | 0 | 0 |
| Short-term debt | 24 224 | 19 558 | 81 101 | 57 460 | 21 057 | 47 838 | 39 235 | 39 812 | 27 221 | 97 294 |
| Total debt | 24 224 | 103 218 | 86 405 | 58 010 | 70 304 | 47 838 | 53 625 | 57 406 | 27 221 | 97 294 |
EBITDA margin
-2.1%
This company
15.8%
Market median
-113% vs market
20152024
Equity ratio
63.1%
This company
38.2%
Market median
+65% vs market
20152024
Return on equity
-16.4%
This company
18.4%
Market median
-189% vs market
20152024
Net profit margin
-13.1%
This company
8.1%
Market median
-262% vs market
20152024
Asset turnover
0.79×
This company
1.12×
Market median
-29% vs market
20152024
Debt / equity
0.58×
This company
0.62×
Market median
+6% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AJ Chief Auditor | Chief Auditor | 2025 | — | — |
RK External Signatory | External Signatory | 2022 | — | — |
JL Chief Auditor | Chief Auditor | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Chairman | 2025 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
CAREDX INC | Company | 100.0% | 100.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CAREDX INC
CareDx AB (this company)CAREDX LAB SOLUTIONS INCCaredx Pty LtdCAREDX PTY LTDCaredx Lab Solutions IncBoard members of CareDx AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Jakob Rinzén | Chief Auditor | 0 companies |
| Reginald Kim Seeto | External Signatory | 0 companies |
| Jonas Lars Lindgren | Chief Auditor | 0 companies |
| Anna Märtha Hedlund | Board of Directors | 0 companies |
| Jessica Meng | Chairman | 0 companies |
| Peter Karl Wilhelm Maag | Chairman | 0 companies |
| Ingrid Carina Lycke | Board of Directors | 0 companies |
| ABHISHEK Jain | Chairman | 0 companies |
| Alexander Laurence Johnson | Board of Directors | 0 companies |